DV
Dividend Vision

VRTX — Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc. (VRTX)

Its deepest 1-year drawdown was 15.2%.

VRTX is a single-stock equity position in Vertex Pharmaceuticals Inc., a biopharmaceutical company, rather than a diversified ETF portfolio. The stock distributes dividends on a quarterly basis, though specific yield and expense ratio data are not currently available. This holding appeals primarily to income-focused investors seeking exposure to the pharmaceutical sector through a established company with a dividend payment history.

VRTX key facts

Asset type
Stock
Asset class
Equity
Inception date
07/24/1991
Distribution frequency
None
Last close
$505.75
Market cap
$128,187,867,136
Average volume
1130500.0
Beta
0.305
Payout ratio
0.0
P/E ratio
30.1221
Forward P/E
27.4725
EPS
$16.79